K. Atikeler

Discount Distribution Analysis of Original Medicines Which Has No Generics In Turkey

In the analysis, “Detailed Price List” data published on the website of the Ministry of Health’s Turkish Medicines and Medical Devices Agency(TMMDA) and “Annex 4-A Funded Medicines List” data published by Social Security Institution (SSI) were used. The lists were merged using the Excel software and generic medicine including genericized original medicines with different pricing and payment conditions compared to original medicines with no generics and other specific medicines such as blood products, enteral nutrition products, etc. and specific conditions such as medicines with no reimbursement were excluded. The analysis was made with a total of 568 original medicines with no generic. Exfactory prices were used in the analysis. The reference prices of all original medicines (100 %) are calculated by multiplying their actual reference price values with the periodic Euro value in the price list used in Turkey. In this analysis the mandatory discount rate for original drugs of 41% discount is mostly implemented by SSI. In rare cases, higher or lower discount rate can be applied. This is compatible with the implementation of the original drug reimbursement policy rules. However, further analysis should be done to obtaining more detailed information. Results